Upon completion of rigorous phase-3 trials, the FDA granted approval for tesamorelin therapy in 2010 in HIV-associated lipodystrophy
Michela Starace was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions
Predicting responsiveness to GLP-1 pathway drugs using real-world data
Understanding this distinction helps explain why many commonly used pain medications particularly corticosteroids can provide short-term symptom relief while quietly worsening long-term metabolic, immune, and tissue health
The concentrations of tumor necrotic factor- (TNF-), interferon- (IFN-), interleukin-6 (IL-6), C-reactive protein (CRP), interleukin-10 (IL-10), and transforming growth factor-1 (TGF-1) were measured using specific ELISA kits according to the method described by Mani et al